Gujarat-based Penny Stock Jumps to Upper Circuit on Strategic Agro R&D & Infrastructure Initiatives Post-QIP

On Thursday, shares of Murae Organisor Limited (Formerly known as Earum Pharmaceuticals Limited) hit a 5 per cent upper circuit to Re 0.67 per share from its previous closing of Re 0.64 per share. The stock’s 52-week high is Rs 1.24 per share and its 52-week low is Re 0.47 per share.

Murae Organisor Ltd., an Ahmedabad-based company, has announced its plans to strategically invest in the agro-sector following a proposed Qualified Institutional Placement (QIP) of up to Rs 80 Crore. The company's management is currently evaluating a detailed plan to strengthen its operational capabilities and long-term product value. The key areas under consideration for investment include establishing an Agro Research & Development Laboratory, developing a fully integrated agro-processing, storage, and packaging unit, and implementing digital infrastructure for traceability and supply-chain analytics. These initiatives aim to improve supply chain efficiency and enhance product quality, positioning the company as a forward-integrated agri enterprise.

The company has also provided a non-binding indicative budget for the potential deployment of the Rs 80 Crore fund. A significant portion of the capital, an estimated Rs 25-Rs 30 crore, is earmarked for the agro-processing and packaging infrastructure. Additionally, a substantial amount of Rs 30-Rs 35 crore is allocated for working capital to manage inventory and supplies. Smaller but crucial allocations are planned for setting up the research lab, digital systems, and a contingency fund. This preliminary plan is subject to shareholder and regulatory approvals, with the final deployment strategy to be presented to the Board of Directors upon completion of the fundraising process.

On Thursday, August 7, 2025, the company's shares traded ex-bonus, with a bonus share ratio of 1:10. This means that for every ten shares an investor owned, they received one additional share at no extra cost.

About the Company

Murae Organisor Ltd, incorporated in 2012, operates within the pharmaceutical industry, focusing on the marketing, trading, and distribution of a diverse range of pharmaceutical formulations. The company markets over 120 products under its brand names, such as HYGNEX+, Erolon, and Calcybar, while outsourcing its manufacturing to third-party facilities. In addition to their branded products, Murae also trades in active pharmaceutical ingredients. Their product portfolio spans various therapeutic categories, including antibiotics, antimalarials, antihistamines, analgesics, dermatology products, neurological drugs, gastrointestinal drugs, and various supplements like calcium and multivitamins. Murae maintains an international presence, exporting to more than 15 countries across North America, CIS, Latin America, Africa, and Southeast Asia, with over 60 international products currently under registration.

According to Quarterly Results, the net sales increased by 1,635 per cent to Rs 3.99 crore and net profit increased by 3,200 per cent to Rs 7.44 crore in Q1FY26 compared to Q1FY25. In its annual results, the net sales increased by 33,554 per cent to Rs 854.82 crore and net profit increased by 14,940 per cent to Rs 7.52 crore in FY25 compared to FY24

The company has a market cap of Rs 137 crore and its 100 per cent stake is owned by public shareholders. The stock is up over 40 per cent from its 52-week low of Rs 0.47 per share.

Disclaimer: The article is for informational purposes only and not investment advice.